At study entry, patients demonstrated immune compromise consistent with prior standard of care, including radiation and alkylating chemotherapy. The baseline mean absolute lymphocyte count (ALC) was ...

Impact of 24 months of androgen deprivation therapy (ADT) on physical function in men with nonmetastatic prostate cancer. A phase II study of neoadjuvant docetaxel (D) plus bevacizumab (B) in patients ...

Please provide your email address to receive an email when new articles are posted on . Lymphopenia at diagnosis or during follow-up can predict OS among patients with multiple myeloma. Researchers ...

DEAR DR. ROACH: I am a female and almost 75 years old. My vital signs are always normal, and I am active, but slightly overweight. I get quarterly blood draws, and every reading is in the normal range ...

Identification of functional DNA methylation aberrations associated with outcome in melanoma patients with brain metastasis. This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This ...

Study suggests CD4+ T cells mediate these immune-related toxicities ...

ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced positive results from its ANKTIVA ...

(A) Principal component analysis (PCA) of lymphocyte subsets and factors such as age in Control, LC, and LC-PTB groups, and the joint analysis of LC & LC-PTB. PC1 and PC2 represent the first and ...